Jinxin Fertility Group (JXR) has announced that through the continuous implementation of operational optimization measures, the group has maintained strong growth momentum. In the four months ended April 30, 2026, the number of new patient visits for infertility reached 16,525, a 7.5% increase compared to the same period in 2025. During the same four-month period, the number of egg retrieval cycles totaled 9,010, representing a 5.2% year-on-year growth. Specifically, the number of new infertility consultations in the Greater Bay Area rose by 17.7% compared to the previous year, while overseas egg retrieval cycles surged by 37.3%. In the Chengdu region, both new infertility consultations and egg retrieval cycles experienced a single-digit decline. Meanwhile, egg retrieval cycles in the Kunming and Wuhan regions increased by 15.5% compared to the same period in 2025, maintaining steady growth.